METTL14 may promote HCC progression by modulating m6A -regulated genes, including glutamic oxaloacetic transaminase 2 (GOT2), cysteine sulfonic acid decarboxylase (CSAD), and suppressor of cytokine signaling 2 (SOCS2) (Li et al., 2020b). Here, GOT2 is linked to hepatocellular carcinoma.